Published in Drug Law Weekly, October 11th, 2005
This patent, an extant United States Patent registered by the company, relates to an improved delivery system for the administration of large-molecule pharmaceuticals, particularly through the oral and nasal membranes.
The patent covers formulations for the delivery of peptidic drugs, vaccines, and hormones, and enhances the company's existing drug-delivery platform patent portfolio.
"Generex welcomes this Canadian patent as we proceed along the path to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.